Immune Biosolutions inc.

📍 Sherbrooke, Canada🗓 Founded 2012👥 30 employees💰 Last funded May 2015
Biotechnology Research🌐 immunebiosolutions.com
Website LinkedIn
Immune Biosolutions is a clinical stage biotech company specializing in discovering and engineering avian and human antibodies for therapeutic and diagnostic applications. Our cutting-edge techniques, including phage display and single B cell screening technologies, enable us to engineer custom-fit immunotherapeutic agents. Our discovery platform is available for biotech and pharma partners, providing access to highly conserved mammalian lineage targets and opening up new possibilities for innovative therapeutics. Our biomanufacturing capacity, which has already supported successful internal clinical trials, is also available for partners in a fee-for-service model. Our internal pipeline includes several discovery programs for various cancer and infectious disease indications. Through our platform, we generate diverse antibodies with high binding affinity and novel paratopes, paving the way for exciting new approaches to treating difficult proteins.
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2012
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Canada
2
Frequently asked questions
Who invested in Immune Biosolutions inc.?
Immune Biosolutions inc. has 2 investors on record on gritt.io, 2 mid-stage.
When did Immune Biosolutions inc. last raise funding?
The most recent investment in Immune Biosolutions inc. recorded on gritt.io was in May 2015.
When was Immune Biosolutions inc. founded?
Immune Biosolutions inc. was founded in 2012.
What industry is Immune Biosolutions inc. in?
Immune Biosolutions inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Immune Biosolutions inc. based?
Immune Biosolutions inc. is headquartered in Sherbrooke, Canada.